If a drug is designed to denature enzymes involved in digesting phenylalanine, why would patients treated with this drug develop phenylketonuria?
Answers
Answered by
0
Patients treated with this drug develop phenylketonuria because They lack an enzyme to break down Phenylalanine.
Phenylalanine is an amino acid of the benyzl group. It is a building block of protein and found in dietary sources like meat, fish, eggs, cheese and milk.
The chemical formula of Phenylalanine is C 9 H 11 NO 2.
Answered by
0
Because they lack an enzyme to break down phenylalanine, patients with this drug develops or tends to develop phenylketonuria. Phenylalanine is an essential alpha -amino acid with the formula C₉H₁₁NO₂. It is viewed as a benzyl group substituted for the methyl group of alanine, or a phenyl group in place of a terminal hydrogen of alanine.
Similar questions